PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of neuroncolAboutAuthor GuidelinesEditorial BoardNeuro-Oncology
 
Neuro-oncol. 2004 October; 6(4): 482–484.
PMCID: PMC1872010

SOCIETY NEWS AND ANNOUNCEMENTS

Anyone in the neuro-oncology profession may submit to the journal announcements of meetings, conferences, and funding opportunities of interest to colleagues. Please send announcements to Oliver Bögler, Ph.D., Department of Neurosurgery and Hermelin Brain Tumor Center, 2799 West Grand Boulevard, Detroit, MI 48202, USA (Telephone: 313-916-7293; E-Fax: 425-732-8379; E-mail: gro.cno-oruen-cos@swenyteicos).

Society for Neuro-Oncology Headquarters

Correspondence to the Society should be sent to Society for Neuro-Oncology, Post Office Box 890886, Houston, TX 77289-0886, or in care of Jan Esenwein, 4617 Birch Street, Bellaire, TX 77401-5509, USA (Telephone: 713-349-0952; Fax: 832-201-8129; E-mail: gro.cno-oruen-cos@naj or gro.cno-oruen-cos@pihsrebmem).

Note of Thanks to William M. Shields and Associates

The Society for Neuro-Oncology gratefully acknowledges the pro bono accounting services performed by William M. Shields and Associates, 8980 Lakes at 610 Drive, Houston, TX 77054, USA. Since SNO was founded in 1995, Mr. Shields and members of his firm have provided advice and each year prepared our Form 990 (Return of Organization Exempt from Income Tax). In the past year, they also took on oversight of our State and Federal Payroll reporting. The valuable services they have provided to our organization, at no cost to us, are very much appreciated.

Brain Tumor Network 2005 Research Awards in Quality of Life

Brain Tumor Network, the professionals’ resource for advancing quality of life, is seeking grant proposals from researchers throughout the United States and Canada who are studying quality of life in neuro-oncology patients and families. Funding for two awards is provided by the American Brain Tumor Association and by the Tim & Tom Gullikson Foundation. Applications and information are available at www.braintumornetwork.org.

National Brain Tumor Foundation (NBTF) Awards 2004 Research Grants

In June 2004, NBTF was pleased to provide research funding to the following researchers:

Andrew Bryce Pediatric Grant: $25,000

William C. Broaddus, M.D., Ph.D., Virginia Commonwealth University

Project Title: Use of Phosphoinositide Analogues to Enhance Chemosensitivity: A Novel Adjuvant Chemotherapeutic for Medulloblastoma

Joan Riordan Quality of Life Grant: $20,000

Denise Correa, Ph.D., ABPP-CN, Memorial Sloan-Kettering Cancer Center

Project Title: Long-Term Cognitive Outcome in Low Grade Glioma Patients

Oligodendroglioma Grants: $50,000

David Eisenstat, M.D., University of Manitoba

Project Title: Hypoxia and the Death Gene BNIP3 in Oligodendroglioma

Catherine L. Nutt, Ph.D., Massachusetts General Hospital

Project Title: Molecular Profile-Based Development of Accurate Immunohistochemical Markers for Human Oligodendrogliomas

Steven J. Bryant Research Grant: $25,000

Maciej S. Lesniak, M.D., The University of Chicago,

Project Title: IL13R-alpha2 Peptide Vaccine Against Glioma

Accelerate Brain Cancer Cure (ABC2) and the NBTF Partner to Fund GBM Survival Study

ABC2 and the NBTF have partnered to fund an epidemiology study being conducted at the University of California at San Francisco entitled “Evaluation of non-synonymous coding single nucleotide polymorphisms (SNPs) in relation to glioblastoma multiforme (GM) prognosis and etiology.” This population-based study, led by Dr. Margaret Wrensch, examines the genetics of glioblastoma as it relates to survival. This study will examine survival in relationship to variation in several thousand polymorphisms in potentially relevant genes and chromosomal regions. Survival information related to some of these factors, such as inherited variation I metabolism and DNA repair, might be useful to clinicians in planning and refining treatments.

Epidemiology Conference Supported by NBTF

In June 2004, NBTF sponsored a Brain Tumor Etiology Consortium meeting of international researchers searching for causes of adult brain tumors. The meeting was organized by the Central Brain Tumor Registry of the U.S. (CBTRUS). The short-term goal of the meeting was the establishment of three research groups focusing on adult genetic/environmental susceptibility and brain tumor linkage. The long-term goal is the development of research that could successfully compete for extramural NIH grant support. The next meeting of the consortium will be held at the SNO meeting in November in Toronto. For more information about this consortium, please contact Rob Tufel at NBTF (415-834-9970 or gro.romutniarb@lefut).

Brain Tumor Epidemiology Consortium

The Brain Tumor Epidemiology Consortium (BTEC) is a self-directing group of population researchers committed to developing multicenter, interdisciplinary collaborations to advance our understanding of etiology, outcomes, and prevention of brain tumors. The BTEC nucleus formed at a 2002 National Cancer Institute–sponsored meeting to further molecular epidemiology studies of brain tumors based on gene-environment interactions. We subsequently expanded the group’s international representation and its representation of pediatric researchers and formulated action plans in four areas: adult gliomas, pediatric tumors, family studies, and meningiomas. BTEC meetings are set for November 18, 2004, at the SNO Annual Meeting and for May 2005 at the World Federation of Neuro-Oncology meeting. The planning committee (Jill Barnholtz-Sloan, Melissa Bondy, Faith Davis, Peter Inskip, Carol Kruchko, and Susan Preston-Martin) thanks the many individuals who have supported this initiative. In particular, we acknowledge the financial support of the NBTF and the Pediatric Brain Tumor Foundation of the United States and the organizational support of the CBTRUS and the Healing Exchange Brain Trust. Individuals who wish to know more about BTEC activities should contact Faith Davis ( ude.ciu@deyaf) or Melissa Bondy ( gro.nosrednadm@ydnobm).

UPCOMING MEETINGS

Nationwide Caregiver Workshops Offered by National Brain Tumor Foundation (NBTF) September 11, 2004, Massachusetts General Hospital, Boston, Massachusetts, USA October 30, 2004, City of Hope Hospital, Duarte (Greater Los Angeles), California, USA November 13, 2004, Minneapolis Neurology Clinics, Minneapolis, Minnesota, USA

The NBTF is launching a free National Brain Tumor Caregiver Program this fall, consisting of day-long workshops offered to family caregivers of brain tumor patients. These workshops teach practical skills and include topics such as managing symptoms at home, legal issues, understanding cognitive and behavior changes, and end-of-life issues.

Contact: Harriet Patterson, National Brain Tumor Foundation

Telephone: 415-834-9970, ext. 103

E-mail: gro.romutniarb@nosrettap

Information is Power . . . Power is Hope: Connecting Patients, Survivors, Caregivers and Professionals, The Brain Tumor Society Sixth Educational Symposium October 29–30, 2004, Newton, Massachusetts, USA

The Brain Tumor Society will hold a symposium and annual meeting at the Boston Newton Marriott. Keynote speakers are Dr. Henry Friedman and Dr. Robert Martuza.

Contact: Sarah Duggan, Director of Education and Support

Telephone: 800-770-8287

E-mail: gro.stbt@troppus.

Web site: www.tbts.org

Ninth Annual Meeting of the Society for Neuro-Oncology (SNO) November 18–21, 2004, Toronto, Ontario, Canada

The ninth annual meeting of the Society for Neuro-Oncology will be held in Toronto. For details, see the Call for Abstracts in the April issue of this journal or the information online (www.soc-neuro-onc.org or www.dukeupress.edu/neuro-oncology).

World Federation of Neuro-Oncology II/European Association for Neuro-Oncology VI (WFNO-II/EANO-VI) May 5–8, 2005, Edinburgh, United Kingdom

The second quadrennial meeting of the World Federation of Neuro-Oncology, in conjunction with the sixth European Association for Neuro-Oncology meeting (WFNO-II/EANO-VI), will be held at the Edinburgh International Conference Centre in The Exchange district, at the center of Edinburgh. The Advance Programme and the registration and accommodation booking forms for the WFNO-II/EANO-VI conference are available at the Web site. The abstract deadline is December 1, 2004. Online registration is available at the Web site. Early registration ends on January 6, and late registration ends on April 1. See our advertisement in this issue.

Contact: WFNO-II/EANO-VI Conference Secretariat Federation of European Cancer Societies Conference Unit Avenue E. Mounier 83 B-1200 Brussels, Belgium

Telephone: +32-(0)-2-775-02-04

Fax: +32-(0)-2-775-02-45

E-mail: eb.scef@6ONAE

Web site: http://www.fecs.be/Conferences/eano6/index.shtml

World Federation of Neurosurgical Societies Thirteenth International Congress of Neurological Surgery June, 19–24, 2005, Marrakesh, Morocco

The Thirteenth World Congress of Neurological Surgery, coinciding with the fiftieth anniversary of the World Federation of Neurosurgical Societies, will take place in Marrakesh from June 19 to 24, 2005. The congress will be hosted by the Moroccan Society of Neurosurgery and the Pan African Association of Neurological Sciences.

Abdeslam El Khamlichi, M.D., President, Thirteenth World Congress of Neurological Surgery

Abdessamad El Azhari, M.D., Chairman, Scientific Program Committee

Edward R. Laws, M.D., F.A.C.S., President, World Federation of Neurosurgical Societies

Contact: The Congress Secretariat, 13th World Congress of Neurological Surgery Hôpital des Spécialités, Department of Neurosurgery P.O. Box 6444 Rabat-Instituts Rabat, Morocco

Telephone: 212-37-77-55-61

Fax: 212-37-77-55-64

E-mail: am.ten.mai@hcn2hf, am.ten.mai@hsekarramsnfw, gro.5002hsekarram@ofni

Web site: www.marrakesh2005.org

Second International CNS Germ Cell Tumor Conference November 18–21, 2005, Los Angeles, California, USA

The Second International CNS Germ Cell Tumor Conference will be held at Univeral City in Los Angeles. The conference organizer is Jonathan L. Finlay, M.D.


Articles from Neuro-Oncology are provided here courtesy of Society for Neuro-Oncology and Oxford University Press